The recent Pharma Meets AI conference in Barcelona showcased how artificial intelligence is beginning to yield measurable returns on investment (ROI) in the pharmaceutical sector.
At the event, discussions centered on the evolving role of AI in enhancing pharmaceutical commercial and medical operations. Despite the widespread adoption of AI, the challenge of translating these technologies into tangible business results remains significant. Sam Rolfe, sales director EMEA at Exeevo, pointed out that successful AI initiatives require more than just experimentation; they must show clear, quantifiable benefits. Fragmented data environments and misalignment among people, processes, and technology continue to hinder the effectiveness of AI applications.
Exeevo showcased its “Ask-Nova” solution, which integrates AI into daily workflows, assisting field teams with tasks like meeting prep and CRM data entry. This tool aims to alleviate administrative burdens, allowing representatives to concentrate on high-value interactions with healthcare professionals. Rolfe highlighted that AI-driven workflow tools can lead to significant time savings—reducing administrative tasks by 30-40%—and can achieve ROI within six months, thereby enhancing operational efficiency and data quality.
This conference underscores a pivotal moment for the pharmaceutical industry, as the integration of AI tools not only streamlines operations but also fosters better engagement with healthcare providers, potentially transforming how pharmaceutical companies operate in a competitive landscape.